P&G R&D chief granted 3,519 stock options
A senior Procter & Gamble officer received a new stock option grant and reported updated direct and plan-based share holdings.
Rhea-AI Filing Summary
PROCTER & GAMBLE Co (PG) reported that Moses Victor Javier Aguilar, the company’s Chief Research, Development & Innovation Officer, received a grant of stock options for 3,519 shares on September 15, 2026, with an exercise price of $146.67 per share, exercisable beginning September 14, 2029 and expiring September 15, 2036. Following this grant, he holds 49,511.0935 shares of common stock directly, plus 7,476.1294 shares held through a retirement plan trustee and 428.6033 shares held through an International Stock Ownership Plan (Mexico) trustee; no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,519 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
stock option financial
exercise price financial
retirement plan trustee financial
International Stock Ownership Plan (Mexico) financial
Rule 10b5-1 trading plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PG disclose for Moses Victor Javier Aguilar?
What is the exercise price of the new stock options reported by PG?
What indirect holdings in PG stock does Moses Victor Javier Aguilar report?
Were the PG insider transactions reported under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.